Salvage Pembrolizumab Ups Overall Survival in Advanced Urothelial Carcinoma

Pembrolizumab is associated with longer overall survival and fewer treatment-related toxicities vs chemotherapy for patients with advanced urothelial carcinoma.

Source: CancerNetwork - February 17, 2017 Category: Cancer & Oncology Authors: Bryant Furlow Tags: ASCO Genitourinary Cancers Symposium News Source Type: news